Inozyme

About:

Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially.

Website: http://www.inozyme.com/

Twitter/X: inozyme

Top Investors: RA Capital Management, New Enterprise Associates, Longitude Capital, Rock Springs Capital, Sofinnova Investments

Description:

Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially disease-modifying therapies to help children who are affected with rare, but severe and debilitating disorders of metabolism. The company's enzyme replacement therapy provides the treatment of Generalized Arterial Calcification of Infancy (GACI) and Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), enabling patients to treat diseases characterized by mineral imbalances in the body.